ID   CK2N1_RAT               Reviewed;          78 AA.
AC   Q9JI15;
DT   10-JUN-2008, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   24-JUL-2024, entry version 121.
DE   RecName: Full=Calcium/calmodulin-dependent protein kinase II inhibitor 1;
DE   AltName: Full=calcium/calmodulin-dependent protein kinase II inhibitor alpha;
DE            Short=CaM-KIINalpha;
DE            Short=CaMKIINalpha;
GN   Name=Camk2n1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, INTERACTION WITH CAMK2A AND CAMK2B,
RP   SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND MUTAGENESIS OF ARG-43; ILE-58
RP   AND 59-LYS--ALA-61.
RX   PubMed=11182241; DOI=10.1016/s0306-4522(00)00520-0;
RA   Chang B.H., Mukherji S., Soderling T.R.;
RT   "Calcium/calmodulin-dependent protein kinase II inhibitor protein:
RT   localization of isoforms in rat brain.";
RL   Neuroscience 102:767-777(2001).
RN   [2]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=31327268; DOI=10.1161/hypertensionaha.118.12409;
RA   Alfazema N., Barrier M., de Proce S.M., Menzies R.I., Carter R.,
RA   Stewart K., Diaz A.G., Moyon B., Webster Z., Bellamy C.O.C., Arends M.J.,
RA   Stimson R.H., Morton N.M., Aitman T.J., Coan P.M.;
RT   "Camk2n1 Is a Negative Regulator of Blood Pressure, Left Ventricular Mass,
RT   Insulin Sensitivity, and Promotes Adiposity.";
RL   Hypertension 74:687-696(2019).
CC   -!- FUNCTION: Potent and specific inhibitor of CaM-kinase II (CAMK2)
CC       (PubMed:11182241). Plays a role in the maintenance of long-term
CC       retrieval-induced memory in response to contextual fear (By
CC       similarity). Modulates blood pressure and vascular reactivity via
CC       regulation of CAMK2 activity in addition to regulation of left
CC       ventricular mass (PubMed:31327268). Mediates the NLRP3 inflammasome in
CC       cardiomyocytes via acting as an inhibitor of the MAPK14/p38 and
CC       MAPK8/JNK pathways, thereby regulating ventricular remodeling and
CC       cardiac rhythm post-myocardial infarction (By similarity). Negatively
CC       effects insulin sensitivity and promotes lipid formation in adipose
CC       tissues independent of CAMK2 signaling (PubMed:31327268).
CC       {ECO:0000250|UniProtKB:Q6QWF9, ECO:0000269|PubMed:11182241,
CC       ECO:0000269|PubMed:31327268}.
CC   -!- SUBUNIT: Interacts with CAMK2B; the presence of Ca(2+)/calmodulin
CC       increases the interaction but is not essential (PubMed:11182241).
CC       Interacts with CAMK2A; this interaction requires CAMK2A activation by
CC       Ca(2+) (PubMed:11182241). {ECO:0000269|PubMed:11182241}.
CC   -!- SUBCELLULAR LOCATION: Synapse {ECO:0000250|UniProtKB:Q6QWF9}. Cell
CC       projection, dendrite {ECO:0000269|PubMed:11182241}. Postsynaptic
CC       density {ECO:0000250|UniProtKB:Q6QWF9}.
CC   -!- TISSUE SPECIFICITY: Brain specific (PubMed:11182241). Highly expressed
CC       in frontal cortex, hippocampus, olfactory bulb, caudate-putamen and
CC       cerebellum (at protein level) (PubMed:11182241).
CC       {ECO:0000269|PubMed:11182241}.
CC   -!- DISRUPTION PHENOTYPE: Knockout in a spontaneously hypertensive rat
CC       model results in decreased blood pressure and vascular reactivity to N-
CC       omega-Nitro-L-arginine methyl ester hydrochloride (PubMed:31327268).
CC       Increased renal and serum endothelial nitric oxide synthase and serum
CC       nitrate levels (PubMed:31327268). Reduced fasting plasma glucose
CC       concentrations and a 23% decrease in visceral and brown adipose tissue
CC       relative mass, resulting from a decrease in adipocyte number
CC       (PubMed:31327268). {ECO:0000269|PubMed:31327268}.
CC   -!- SIMILARITY: Belongs to the CAMK2N family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF271156; AAF75281.1; -; mRNA.
DR   RefSeq; NP_775459.1; NM_173337.1.
DR   PDB; 3KL8; X-ray; 3.37 A; B/D/F/H/J=42-58.
DR   PDBsum; 3KL8; -.
DR   AlphaFoldDB; Q9JI15; -.
DR   SMR; Q9JI15; -.
DR   BioGRID; 251978; 1.
DR   DIP; DIP-58987N; -.
DR   IntAct; Q9JI15; 1.
DR   STRING; 10116.ENSRNOP00000021864; -.
DR   PhosphoSitePlus; Q9JI15; -.
DR   PaxDb; 10116-ENSRNOP00000021864; -.
DR   Ensembl; ENSRNOT00060010577; ENSRNOP00060007838; ENSRNOG00060006453.
DR   GeneID; 287005; -.
DR   KEGG; rno:287005; -.
DR   UCSC; RGD:708430; rat.
DR   AGR; RGD:708430; -.
DR   CTD; 55450; -.
DR   RGD; 708430; Camk2n1.
DR   eggNOG; ENOG502S6QW; Eukaryota.
DR   HOGENOM; CLU_197183_0_0_1; -.
DR   InParanoid; Q9JI15; -.
DR   OrthoDB; 5341210at2759; -.
DR   PhylomeDB; Q9JI15; -.
DR   TreeFam; TF333175; -.
DR   PRO; PR:Q9JI15; -.
DR   Proteomes; UP000002494; Chromosome 5.
DR   Bgee; ENSRNOG00000016322; Expressed in frontal cortex and 19 other cell types or tissues.
DR   GO; GO:0030425; C:dendrite; IDA:HGNC-UCL.
DR   GO; GO:0043025; C:neuronal cell body; IDA:HGNC-UCL.
DR   GO; GO:0014069; C:postsynaptic density; ISO:RGD.
DR   GO; GO:0045202; C:synapse; ISS:UniProtKB.
DR   GO; GO:0008427; F:calcium-dependent protein kinase inhibitor activity; IDA:HGNC-UCL.
DR   GO; GO:0019901; F:protein kinase binding; IDA:HGNC-UCL.
DR   GO; GO:0004860; F:protein kinase inhibitor activity; ISO:RGD.
DR   GO; GO:0007268; P:chemical synaptic transmission; IC:HGNC-UCL.
DR   GO; GO:0007616; P:long-term memory; ISS:UniProtKB.
DR   GO; GO:0050729; P:positive regulation of inflammatory response; ISS:UniProtKB.
DR   GO; GO:0035774; P:positive regulation of insulin secretion involved in cellular response to glucose stimulus; IMP:RGD.
DR   GO; GO:0003084; P:positive regulation of systemic arterial blood pressure; IMP:RGD.
DR   InterPro; IPR026779; Camk2n.
DR   PANTHER; PTHR31007; CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE II INHIBITOR 2; 1.
DR   PANTHER; PTHR31007:SF3; CALCIUM_CALMODULIN-DEPENDENT PROTEIN KINASE II INHIBITOR 1; 1.
DR   Pfam; PF15170; CaM-KIIN; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cell projection; Protein kinase inhibitor;
KW   Reference proteome; Synapse.
FT   CHAIN           1..78
FT                   /note="Calcium/calmodulin-dependent protein kinase II
FT                   inhibitor 1"
FT                   /id="PRO_0000338395"
FT   REGION          41..68
FT                   /note="CAMK2 inhibitory domain"
FT   MUTAGEN         43
FT                   /note="R->P: Reduces at least 100-fold the inhibitory
FT                   potency; when associated with 59-K--A-61."
FT                   /evidence="ECO:0000269|PubMed:11182241"
FT   MUTAGEN         58
FT                   /note="I->S: Slightly phosphorylated."
FT                   /evidence="ECO:0000269|PubMed:11182241"
FT   MUTAGEN         59..61
FT                   /note="EDD->KLA: Reduces at least 100-fold the inhibitory
FT                   potency; when associated with P-43."
FT                   /evidence="ECO:0000269|PubMed:11182241"
FT   HELIX           47..50
FT                   /evidence="ECO:0007829|PDB:3KL8"
SQ   SEQUENCE   78 AA;  8513 MW;  A89A9E5DA11B8E61 CRC64;
     MSEVLPYGDE KLSPYGDGGD VGQIFSCRLQ DTNNFFGAGQ SKRPPKLGQI GRSKRVVIED
     DRIDDVLKTM TDKAPPGV
//
